Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.00
Bid: 200.00
Ask: 196.00
Change: 2.00 (1.03%)
Spread: -4.00 (-2.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 194.00
NXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealings

19 Jul 2022 13:57

RNS Number : 0145T
Norcros PLC
19 July 2022
 

Norcros plc ("Norcros" or "the Company")

Director Dealings - APSP Share Option and Deferred Share awards

 

Director/PDMR Shareholding

Norcros announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following Directors under the Company's Approved Performance Share Plan (the "APSP") and Deferred Bonus Plan (the "DBP") on 19 July 2022.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation ("MAR"), provides further detail.

APSP Share Option Awards

The Company has today granted the following unapproved nil cost share option awards under the APSP in respect of the current financial year (the "APSP Awards") to two Executive Directors of the Company over ordinary shares of ten pence each in the Company ("Ordinary Shares"). 

Under the APSP, awards are made subject to performance targets relating to improvements in the Company's Earnings Per Share ("EPS"). Vesting of these Ordinary Shares will be subject to achieving aggregate diluted EPS targets over a three year performance period, starting with the 2023 financial year.

The APSP Awards will normally vest on the third anniversary of their grant, subject to satisfactory achievement of the performance targets. No consideration was paid for the APSP Awards.

Name

Number of Ordinary Shares subject to the APSP Award

Nick Kelsall

218,348

James Eyre

133,027

 

Bonus payment - Deferred Share Awards

Under the annual bonus scheme, 50 per cent. of an Executive Director's total bonus for the year is satisfied in cash, with the other 50 per cent. in the form of nil cost options under the DBP. These options represent 50 per cent. of the bonuses earned by the Executive Directors for the 2022 financial year.

Norcros therefore also announces the grant of the following nil cost share option awards under the DBP in respect of the year ended 31 March 2022 (the "Deferred Awards") to the relevant Executive Director of the Company over Ordinary Shares.

Name

Number of Ordinary Shares subject to the Deferred Bonus Plan Award

Nick Kelsall

James Eyre

89,098

39,894

 

The Deferred Awards will normally vest on the third anniversary of their grant. Because these shares represent part of a bonus already earned, no consideration was paid for the Deferred Awards and no consideration is due to be payable on vesting.

MAR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Kelsall

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Norcros plc

b)

LEI

213800EIMJZZA1GBIE18

4 A

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Share of 10 pence

 

 

GB00BYYJL418

 

b)

 

Nature of the transaction

 

Grant of 218,348 options under the Company's Approved Performance Share Plan (the "APSP") and 89,098

 options under the Deferred Bonus Plan (the "DBP") on 19 July 2022

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

n/a

 

n/a

d)

 

Aggregated information

- Aggregated volume

- Price

 

n/a

n/a

 

e)

 

Date of the transaction

 

19 July 2022

f)

 

Place of the transaction

 

Wilmslow, Cheshire, England

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Eyre

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Norcros plc

b)

LEI

213800EIMJZZA1GBIE18

4 A

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Share of 10 pence

 

 

GB00BYYJL418

 

b)

 

Nature of the transaction

 

Grant of 133,027 options under the Company's Approved Performance Share Plan (the "APSP") and 39,894 options under the Company's Deferred Bonus Plan (the "DBP") on 19 July 2022

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

n/a

n/a

d)

 

Aggregated information

- Aggregated volume

- Price

 

n/a

n/a

 

e)

 

Date of the transaction

 

19 July 2022

f)

 

Place of the transaction

 

Wilmslow, Cheshire, England

 

 

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Chief Executive Officer

James Eyre, Chief Financial Officer

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUQAMUPPGPB
Date   Source Headline
9th Feb 20175:18 pmRNSHolding(s) in Company
18th Jan 20171:04 pmRNSHolding(s) in Company
12th Jan 201712:15 pmRNSHolding(s) in Company
16th Dec 20169:29 amRNSEmployee SAYE awards and director shareholding
17th Nov 20167:00 amRNSInterim Results
8th Nov 20162:25 pmRNSDirector Declaration
3rd Nov 20162:03 pmRNSHolding(s) in Company
21st Oct 201612:07 pmRNSSecond Price Monitoring Extn
21st Oct 201612:02 pmRNSPrice Monitoring Extension
11th Oct 20167:00 amRNSTrading Update
28th Sep 20162:09 pmRNSDirectors Dealings
20th Sep 20169:16 amRNSVoting Rights and Capital
6th Sep 201612:47 pmRNSHolding(s) in Company
5th Sep 20164:40 pmRNSSecond Price Monitoring Extn
5th Sep 20164:35 pmRNSPrice Monitoring Extension
1st Sep 20167:00 amRNSBlock Listing Six Monthly Return
27th Jul 20165:21 pmRNSDirectors Dealing
27th Jul 201612:58 pmRNSResult of AGM
27th Jul 20167:00 amRNSAGM Trading Statement
15th Jul 20162:41 pmRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSBlock listing Interim Review
30th Jun 20162:22 pmRNSHolding(s) in Company
23rd Jun 20163:28 pmRNSAnnual Financial Report
21st Jun 20166:30 pmRNSHolding(s) in Company
14th Jun 20167:00 amRNSResults for the year ended 31 March 2016
4th May 20166:22 pmRNSHolding(s) in Company
26th Apr 201610:36 amRNSHolding(s) in Company
20th Apr 20163:14 pmRNSDirector Declaration
18th Apr 20162:14 pmRNSHolding(s) in Company
15th Apr 20164:31 pmRNSHolding(s) in Company
14th Apr 20167:00 amRNSTrading Update
13th Apr 20164:06 pmRNSHolding(s) in Company
11th Apr 20169:36 amRNSHolding(s) in Company
1st Apr 20167:00 amRNSAcquisition of Abode Home Products Ltd
31st Mar 20167:00 amRNSBoard Appointment
16th Mar 201612:55 pmRNSHolding(s) in Company
1st Mar 20161:37 pmRNSBlocklisting Interim Review
23rd Feb 20161:20 pmRNSHome State Announcement
23rd Feb 201612:50 pmRNSHome Trading Announcement
19th Feb 20164:35 pmRNSPrice Monitoring Extension
30th Nov 20159:24 amRNSHolding(s) in Company
23rd Nov 20157:00 amRNSDirectorate Change
16th Nov 20155:28 pmRNSHolding(s) in Company
12th Nov 20157:00 amRNSInterim Results
10th Nov 201511:22 amRNSHolding(s) in Company
21st Oct 20159:02 amRNSNotice of Interim Results
8th Oct 20157:00 amRNSTrading Update
30th Sep 20155:25 pmRNSDirector/PDMR Shareholding
30th Sep 20157:00 amRNSShare Capital Consolidation
28th Sep 20155:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.